CHICAGO, Dec. 1, 2014 /PRNewswire/ -- Pfanstiehl has announced the launch of a new high purity, low endotoxin, Mannitol (USP/NF, EP, JP), manufactured in the US under strict cGMP, ICH Q7 compliant conditions. "Mannitol is a tried and true platform excipient used in a wide range...
Pfanstiehl is an Illinois-based biotechnology firm that produces and supplies cGMP-produced, injectable-grade excipients and bioprocessing solutions for the healthcare sector.